Author

K. La Perle

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. E. Stark· 1 shared A. Nazareno· 1 shared A. Orlacchio· 1 shared A. Tessari· 1 shared C. C. Breece· 1 shared D. P. Carbone· 1 shared D. Palmieri· 1 shared F. Amari· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. E. Stark

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tagging allows faithful tracing of expression and enhances biochemical detection of Ran Binding Protein 9 in vivo and reveals its interaction with Nucleolin.

S. Soliman, A. E. Stark, M. Gardner, S. W. Harshman, C. C. Breece, F. Amari, A. Orlacchio, M. Chen, A. Tessari, J. A. Martin, R. Visone, M. A. Freitas, K. La Perle, D. Palmieri, V. COPPOLA

The paper generates a novel mouse strain with a tagged RanBP9 protein, enabling reliable detection and revealing its interaction with Nucleolin.

bioRxiv · Dec 3, 2019Bioengineering

Identification of frequent activating HER2 mutations in primary canine pulmonary adenocarcinoma

G. Lorch, K. Sivaprakasam, V. Zismann, N. Perdigones, T. Contente-Cuomo, A. Nazareno, S. Facista, S. Wong, K. Drenner, W. S. Liang, J. M. Amann, S. L. Sinicropi-Yao, M. J. Koenig, K. La Perle, T. G. Whitsett, , W. P. D. Hendricks

This study identifies HER2 mutations in canine pulmonary adenocarcinomas, finding V659E mutations in 38% of cases and their association with drug sensitivity.

bioRxiv · Feb 25, 2019 · PreprintCancer Biology